Arbutus Biopharma (ABUS) Interest Coverage Ratio Growth (3y) (2017 - 2026)
Arbutus Biopharma (ABUS) Interest Coverage Ratio Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -42.41% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 28.11% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -6.89% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 79.27% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 29.47% |
| 10 | Arbutus Biopharma | 880.36 Mn | 785.13 Mn | - | 340.55% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 340.55% |
| Dec 31, 2025 | -32.53% |
| Sep 30, 2025 | -108.53% |
| Jun 30, 2025 | 56.26% |
| Mar 31, 2025 | -248.48% |
| Dec 31, 2024 | -238.49% |
| Sep 30, 2024 | -212.79% |
| Jun 30, 2024 | -108.83% |
| Mar 31, 2024 | -78.38% |
| Dec 31, 2023 | -184.61% |
| Sep 30, 2023 | -221.00% |
| Jun 30, 2023 | -107.94% |
| Mar 31, 2023 | -90.96% |
| Dec 31, 2022 | 26.09% |
| Sep 30, 2022 | 20.54% |
| Jun 30, 2022 | -91.90% |
| Mar 31, 2022 | 76.16% |
| Dec 31, 2021 | 29.44% |
| Mar 31, 2021 | 51.41% |
| Dec 31, 2020 | 70.58% |